Sirdás sisdollui
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Aiddostahtton
  • The value of bone turnover mar...
  • Čujuhandieđut
  • Deakstadieđáhus
  • Sádde šleađgaboasttain
  • Čálit
  • Doalvvo čujuhusa
    • Doalvun: RefWorks
    • Doalvun: EndNoteWeb
    • Doalvun: EndNote
  • Bissovaš liŋka
The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.

The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.

Čájet eará veršuvnnaid (1)
Bibliográfalaš dieđut
Váldodahkkit: van Staa, T, Eastell, R, Barton, I, Rizzoli, R, Javaid, M, Cooper, C
Materiálatiipa: Conference item
Almmustuhtton: 2003
  • Oažžasuvvandieđut
  • Govvádus
  • Eará veršuvnnat (1)
  • Geahča maid
  • Bargiidšearbma

Geahča maid

  • The value of bone turnover markers in the prediction of vertebral fracture in patients using oral glucocorticoids.
    Dahkki: van Staal, T, et al.
    Almmustuhtton: (2003)
  • PREDICTORS FOR VERTEBRAL FRACTURES AND FRACTURE THRESHOLD IN PATIENTS USING ORAL GLUCOCORTICOIDS
    Dahkki: van Staa, T, et al.
    Almmustuhtton: (2003)
  • Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
    Dahkki: Van Staa, T, et al.
    Almmustuhtton: (2003)
  • Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
    Dahkki: Watts, N, et al.
    Almmustuhtton: (2004)
  • Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
    Dahkki: Watts, N, et al.
    Almmustuhtton: (2004)

Ozu molssaeavttut

  • Ohcanhistorjá
  • Aiddostahtton ohcu

Viečča lasi

  • Bláđe logahallama
  • Bláđe alfabehtalaš ortnegis
  • Dutkka kanálaid
  • Gursagirjjit
  • Ođatlogahallan

Dárbbašatgo veahki?

  • Ohcanráva
  • Jeara girjerájus
  • DJG:t